Harrow Balance Sheet Health

Financial Health criteria checks 3/6

Harrow has a total shareholder equity of $57.6M and total debt of $186.1M, which brings its debt-to-equity ratio to 322.9%. Its total assets and total liabilities are $351.5M and $293.9M respectively.

Key information

322.9%

Debt to equity ratio

US$186.06m

Debt

Interest coverage ration/a
CashUS$74.05m
EquityUS$57.62m
Total liabilitiesUS$293.92m
Total assetsUS$351.54m

Recent financial health updates

Recent updates

Harrow: Spotlight On IHEEZO

Nov 16

Harrow's Focus - Reviving Old Drugs In A Crowded Market

Oct 02

Harrow: 3 Business Models, One Mission

Sep 10

Borrowing Cash To Burn It: The Curious Case Of Harrow

Aug 21

Harrow: The Bull Thesis Is On Track, But Short-Term Challenges Loom

May 02

Harrow's Drug Iheezo Is Off To A Great Start

Feb 19

Harrow: Temporary Disruption In Stock Price Creates Excellent Opportunity

Jan 30

Harrow sells non‑ophthalmic compounding business, terms undisclosed

Oct 05

Harrow Health soars ~27% on FDA nod of anesthesia gel for the surface of the eye

Sep 27

SRK Capital - Harrow Health: Market Missing The Forest For The Trees

Aug 19

These 4 Measures Indicate That Harrow Health (NASDAQ:HROW) Is Using Debt Extensively

Aug 11
These 4 Measures Indicate That Harrow Health (NASDAQ:HROW) Is Using Debt Extensively

Buy Deep Moated, Fast Growing, Superbly Managed Harrow Health Ahead Of New Product Launch

May 23

Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

May 12
Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

Is Harrow Health (NASDAQ:HROW) A Risky Investment?

Dec 15
Is Harrow Health (NASDAQ:HROW) A Risky Investment?

Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

Aug 24
Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

Financial Position Analysis

Short Term Liabilities: HROW's short term assets ($147.1M) exceed its short term liabilities ($95.0M).

Long Term Liabilities: HROW's short term assets ($147.1M) do not cover its long term liabilities ($198.9M).


Debt to Equity History and Analysis

Debt Level: HROW's net debt to equity ratio (194.4%) is considered high.

Reducing Debt: HROW's debt to equity ratio has increased from 58.5% to 322.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable HROW has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: HROW is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 51.9% per year.


Discover healthy companies